International Conference on Systemics, Cybernetics and Informatics

( ICSCI - 2012 )

Conference Dates: February 15 - 18, 2012

Venue: Dr. MCR HRD Institute, Government of Andhra Pradesh, India, Road No. 25, Jubilee Hills, Hyderabad – 500 033

http://www.hrdiap.gov.in ; Ph: +91-40-23548487; Fax:: 23548489; email: adm.ao@hrdiap.gov.in

Organized By: Pentagram Research Centre Pvt Limited

Corporate Address: 201, Venkat Homes, MIGH-59, Mehdipatnam, Hyderabad, Andhra Pradesh, India

Conference Secretariat Address: 1073, Road No. 44, Jubilee Hills, Hyderabad, Andhra Pradesh, India

Web Site: www.icsci.net ; Tel: +91-40-23553986; email: icscimail@yahoo.com

Mission: To Create A Knowledge Based Society

<  ICSCI-2012 Secretariat welcomes Dr. Bishwajit Nag >

International Conference on Systemics, Cybernetics and Informatics is an event organized by Pentagram Research

< The printed book and its online version will have the Volume number in the AIP Conference Proceedings Series, ISSN and ISBN, and will be registered at the Library of Congress >

Dr. Bishwajit Nag

Guest of Honor

Dr. Bishwajit Nag

Dr. Bishwajit Nag is currently the Founder and CEO of RENOVEL DISCOVERIES INC. and NAG RESEARCH LABORATORIES INC. (NRL) where he is involved in developing new generation of technology based natural product drug discovery in diverse areas such as Diabetes, Obesity, Arthritis, Cancer and Neurological diseases.  In 2011 he has launched India’s first natural product based drug discovery company “RENOVEL DISCOVERIES PVT LTD. in Bangalore, India with a subsidiary company in USA as RENOVEL DISCOVERIES INC. in San Francisco, CA.  From 2002-2007 Dr. Nag was the Founder and CEO of BEXEL Pharmaceuticals Inc., CA, in partnership with Orchid Chemicals & Pharmaceuticals of Chennai, India.  From 1996-2001 Dr. Nag served as the founder and chief scientific officer (CSO) at CALYX Therapeutics Inc., Hayward, CA, a technology based molecular drug discovery company for the treatment of Diabetes and Inflammation.  Dr. Nag’s biotech business activity initiated at ANERGEN Inc. where he was the Director of R&D from 1988-1995, a NASDAQ-listed corporation (symbol: ANRG) later acquired by Corixa Corporation.  At Anergen, he was involved in developing recombinant proteins based biologicals for the treatment of a number of autoimmune diseases such as multiple sclerosis (MS), rheumatoid arthritis (RA), Type I diabetes and myasthenia gravis (MG) in collaboration with Novo-Nordisk, Ekzo-Nobel and Zymogenetics Inc (a subsidiary of Bristol-Myer Squib).  Before joining Anergen Inc., Dr. Nag served as a senior scientist in the development of the recombinant tissue plasminogen activator (TPA) at Berlex Biosciences in collaboration with Abbott Laboratories. Dr. Nag received several international honors and awards during his career including American Medal of Honor in 2001, Cambridge International Scientist of the year in 2002, United States National Leadership award in 2003, ABI Hall of Fame award in 2005, George W. Bush Charter Presidential Award in 2007 and Congressional Merit Award in 2008. His extra curriculum activities include outdoor adventures such as cycling, rock-climbing, back-packing and hiking. Dr. Nag is actively involved in sponsoring U-23 cycling team “NRL-RACING TEAM” based in Berkeley California and GO-GET OUTDOOR TEAM based in San Francisco, CA.  He is actively promoting two non-profit organizations: NAG FOUNDATION for assisting financially deprived students for education and MOTIVATION RESEARCH organization for realizing lifestyle potential for individuals.

Home | Contributed Papers | Students Papers | ICSCI-2004 | ICSCI-2005 | ICSCI-2006 | ICSCI-2007 | ICSCI-2008 | ICSCI-2009 | ICSCI-2010 | ICSCI2011 | ICSCI2012 |